Targeted gene delivery is essential for gene therapy involvPerfusion with chelating agents (1 mM EGTA, or 2 mM ing in vivo gene transfer. In the present study we analyzed EDTA) prior to the administration of the vector increased the efficiency and tissue-specificity of gene transfer into the the efficiency to at least 40%. Similar efficiencies were liver with recombinant adenoviruses. Adenovirus vectors obtained in experiments with liver lobes of Rhesus monkcarrying the E. coli lacZ gene (Ad.RSV.␤-gal) and the firefly eys. In vivo administration of AdCMV-luc via ILP resulted luciferase gene (AdCMV-luc) as reporters were adminisin a significantly more efficient (P = 0.028) and also more tered to the liver of adult Wistar rats, either via infusion into reproducible gene transfer when compared to IPI. Although the portal vein (intraportal infusion; IPI) or via perfusion of detectable in both groups, extrahepatic luciferase the vascularly isolated liver (isolated liver perfusion; ILP).
Introduction strategy may not be widely applicable. Apart from the Recent advances in gene transfer technology have made obligatory partial hepatectomy, which is considered a it possible to envisage gene therapy as an attractive major surgical procedure, the results of ex vivo gene therapproach for the treatment of several inherited disorders apy are compromised by the potentially life-threatening of hepatic function, eg familial hypercholesterolemia, complications of hepatocyte transplantation. Furtherphenylketonuria, Crigler-Najjar's disease and hemophimore, a major hurdle in the development of ex vivo gene lia, as well as for acquired disorders such as hepatitis and therapy strategies is the current inability to achieve sufcancer. Hepatic gene therapy can be accomplished via ex ficient grafting of the genetically modified cells. 2, 3 vivo or in vivo gene delivery methods. The ex vivo strategy A more attractive approach would involve the direct requires surgical resection of a liver lobe from which introduction of gene transfer vectors into the liver in vivo. hepatocytes are harvested. The isolated liver cells are For this purpose, several vector systems, including genetically modified in culture and subsequently reimrecombinant adenovirus vectors (rAdV) and retrovirus planted. In this approach, the genetic modification can be vectors, have been studied. Retroviruses require active performed under carefully controlled conditions. In DNA replication for integration into the host cell genome. addition, the genetic modification is strictly limited to the Hepatocytes, however, exhibit a minimal proliferative isolated cells: inadvertent gene transfer into the cells of activity both in vivo and in culture. Although proliferthe gonads that could theoretically result in germ-line ation can be induced by either partial hepatectomy 4, 5 or transmission of the introduced gene(s), can be fully the administration of hepatotoxic agents, 6 ,7 the geneexcluded. Although in clinical trials the feasibility of the transfer efficiencies achieved with retrovirus-mediated ex vivo approach for partially restoring the defective gene transfer in vivo rarely exceed 1%. Adenovirus vectors can also infect nonproliferating cells, thus circumventing the need for induction of liver regeneration.
genetic modification of the target organ. A major concern higher amounts of Ad.RSV.␤-gal, suggesting that the virus concentration was limiting (data not shown). The in this strategy is that the vector spreads to other than the target organ. In vivo gene delivery should, therefore, viability of rat hepatocytes isolated from livers perfused with adenovirus-containing buffer was similar to that of be tissue specific and methods for targeted gene delivery are required. Tissue-specific in vivo gene transfer can be hepatocytes from the mock-infected rats. The influence of chelating agents such as EGTA and accomplished by local administration of the vector to the tissue of interest. For local administration of drugs to the EDTA on the efficiency of gene transfer was evaluated by pretreatment of rat livers with these agents as liver the surgical technique of isolated liver perfusion (ILP) has been used. 13, 14 The technique involves perfusion described in the Materials and methods section. Perfusion of rat livers with buffers supplemented with 1 mm of an intact vascularly iolated liver and is used to date for the treatment of irresectable liver metastases. During EGTA before the recirculation with adenovirus-containing buffers resulted in a significant increase in the ILP high-dose chemotherapeutic agents and tumor necrosis factor are recirculated within the isolated liver amount of ␤-gal-positive hepatocytes. Mean infection percentages of 46.4 ± 0.9% were found after pretreatment circuit. As a result the exposure of extrahepatic tissues is minimal.
13, 14 We decided to explore this potential of ILP with EGTA (Table 1) . Similar results were obtained with the use of 2 mm EDTA (data not shown). Moreover, we for the in vivo delivery of adenovirus vectors.
In the present study the efficiency and tissue specificity found that the use of EGTA or EDTA preperfusion did not affect the viability of the liver cells. of liver-directed gene transfer via ILP was evaluated in a rat model. For this purpose, the efficiency of gene transFollowing the experiments with rats, we studied the efficacy of ex vivo liver perfusion with adenovirus vectors fer via ILP was compared with infusion of the rAdV into the portal vein (intraportal infusion; IPI). We analyzed with liver lobes from Rhesus monkeys. For this purpose, the left lateral liver lobe (±40-60 g) was extracorporally the efficiency of gene transfer to the liver and compared the expression of marker genes in extrahepatic tissues. Ex perfused with buffers containing 2 × 10 9 p.f.u. Ad.RSV.␤-gal. The perfusion methods were identical to those used vivo perfusions of liver (lobes) of rat and monkey origin were performed to establish the optimal conditions for in the experiments with rat livers. toxic effects related to EDTA were observed (data not 
u. AdCMVLuc via intra-portal infusion (n = 10) or by means of recirculation in a vascularly isolated liver (n = 10). The animals were killed 7 days later. The livers as well as various other tissues were removed, homogenized, and lyzed in cell culture lysis reagent. The amounts of cellular proteins present in each sample were determined with the BioRad Protein Assay kit. The luciferase activity present in the homogenates was measured with a luminometer, as described in the Materials and methods section. Each bar in the figure corresponds with one experimental animal.
shown). The animals (n = 4) that underwent EDTA preobtained after intraportal infusion of the rAdV. However, the extrahepatic expression observed in the IPI group treatment showed a slightly higher liver luciferase activity (mean 6.5 × 10 6 light units/mg protein) than the was at least 10-fold higher when compared to the ILP group. In some ILP-treated animals, luciferase activity group (n = 4) in which preperfusion with the chelating agent was omitted (3.0 × 10 6 light units/mg protein). The was detected only in the liver and spleen ( Figure 2 ). difference in luciferase activity between these groups was however not statistically significant (P = 0.14).
Discussion
It has been demonstrated that the majority of the adenovirus particles, administered to experimental animals by
In vivo gene therapy requires targeted delivery of the gene-transfer vehicle to the tissue of choice in order to infusion into the circulation, route to the liver (eg Refs 15 and 16). However, a small percentage of the administered prevent leakage of the vector to non-target tissues. We studied whether in vivo perfusion of a vascularly isolated virus reaches and infects other tissues. This may cause unwanted side-effects, including germ-line transmission.
liver can be used for targeted delivery of a transgene to the liver with recombinant adenoviruses. In vitro infecTherefore, we studied whether in vivo administration of adenovirus particles to the liver by ILP could prevent or tion of isolated hepatocytes and ex vivo perfusion experiments of liver (lobes) from rats and Rhesus monkeys reduce the expression of the marker gene in non-target tissues. The results are summarized in of the exposed hepatocytes expressed the reporter gene.
vascularly isolated liver with a recombinant adenovirus can be used to attain highly efficient gene transfer into At an MOI of 50, in almost all exposed hepatocytes reporter gene expression could be demonstrated (data the liver. This procedure resulted in a significantly higher and also markedly more reproducible expression of the not shown). Toxic effects related to the exposure of the hepatocytes to the adenoviruses were not observed. In marker gene when compared to infusion of the vector into the portal vein. The reason for the large variation these experiments it was shown that adenoviruses have the ability to attach to liver cells at low temperatures.
in hepatic luciferase activity found after IPI is unclear. Accidental spill of the virus during administration can be This feature is an advantage for the ex vivo gene delivery strategy, since transfection at low temperature increases excluded, since intraportal infusion of the adenovirus was performed via a cannula in the pyloric vein, identical the survival rate of the hepatocytes.
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The results of the ex vivo liver (lobe) perfusions demonto the procedure used in the ILP group. In addition, we studied the occurrence of systemic strated that recombinant adenoviruses can be used to obtain efficient gene delivery to hepatocytes in an intact leakage to non-target tissues as a result of adenovirus delivery via IPI or ILP. After intraportal infusion of liver. We observed that perfusion with an EGTA (1 mm) or EDTA (2 mm)-containing buffer before the recircu-2 × 10 9 p.f.u. AdCMV-Luc, the majority of the luciferase activity was found to be present in the liver. However, lation of the adenovirus-containing buffer increased the fraction of transduced cells to approximately 50%. The luciferase activity was also detectable in other tissues. Delivery of the virus by ILP reduced this leakage to nonmechanism for the observed phenomenon is unclear. EGTA and EDTA are used as dissociating agents for the target tissues at least 10-fold. In some of the animals that received AdCMV-Luc by ILP, luciferase activity was conisolation of hepatocytes, 18 so perhaps by their dissociating action these agents make liver cells more susceptible fined to the liver and, albeit at a very low level, to the spleen. The presence in the spleen of adenovirus-vector to infection by adenoviruses. Alternatively, the chelating agents may widen the fenestrae in the sinusoidal endo-DNA after adenovirus-mediated gene transfer to the lungs of Rhesus monkeys has been reported prethelium, thus resulting in an increased assessibility to the liver parenchymal cells. The effect of EGTA and EDTA viously. 9, 10 This suggests that the intrasplenic presence of adenovirus vectors, that in our case had been adminiswas also tested in the ILP group. However, the increased luciferase activity observed in the ILP group was not stattered to the liver, may be caused by migration of the transduced cells to the spleen, rather than by intrasplenic istically significant.
In the in vivo experiments it was established that intratransfection of those cells. The absence of extrahepatic expression in these animals clearly illustrates the feasiportal infusion (IPI) of the adenovirus vector leads to high expression of the reporter gene in the liver, with bility of the ILP technique for achieving liver-specific gene transfer. lower activity in the other organs. A similar tissue distribution was found when the virus was administered via
The potential of the ILP technique for liver-specific drug delivery has been reported previously. 20 The systhe tail vein or the jugular vein (data not shown), confirming the hepatotropism of the adenovirus type 5-temic leakage of anticancer agents during ILP in a porcine model was quantified by measuring the 5-fluoroderived vectors upon systemic administration. 16 It has been reported previously that administration of uracil concentration in systemic plasma with highperformance liquid chromatography. In all experiments, adenovirus vectors does not compromise function and integrity of the rat liver. 19 We confirm and extend these systemic leakage of 5-fluorouracil could be detected. However, significantly lower systemic plasma concenobservations and demonstrate that perfusion of a trations of 5-fluorouracil were found in the experimental Viruses and virus techniques The recombinant adenovirus vector Ad.RSV.␤-gal carries group undergoing isolated liver perfusion than in those who had infusion into the hepatic artery (P Ͻ 0.01). In the E. coli lacZ gene for ␤-galactosidase (␤-gal) under control of the promoter from the Rous sarcoma virus long addition, this group has developed a reliable and highly accurate technique for the continuous measurement of terminal repeat, and contains the SV40 nuclear localization signal to facilitate the detection of protein systemic leakage during isolated liver perfusion in pigs using radiotracers. 21 The feasibility of the vascularly isoexpression. 24 It was kindly provided by Dr Michel Perricaudet (Institut Gustave Roussy, Villejuif, France). lated perfusions in a clinical setting has already been demonstrated in studies in which anticancer agents such AdCMV-Luc, kindly provided by Dr Joachim Herz (University of Texas, Southwestern Medical Center, TX, as mitomycin C 13 , melphalan and tumor necrosis factor 14 were perfused in patients with irresectable colorectal USA), contains the firefly luciferase gene under control of the cytomegalovirus enhancer/promoter. 16 liver metastases. In the clinical studies, systemic leakage of anticancer agents was detectable. In the present study, Plaque assays were performed essentially as described. 23 Briefly, adenovirus stocks were serially we also observed minimal levels of extrahepatic gene expression after delivery of an adenovirus vector to rat diluted in 2 ml Dulbecco's modified Eagle's medium (DMEM) containing 2% horse serum (HS) and added to livers by ILP. The reason for the leakage to other tissues is not clear. It could result from leakage via the right near confluent 911 cells in six-well plates. After 2 h incubation at 37°C, the medium was replaced by F-15 minisuprarenal vein, a small venous branch that originates from the dorsal aspect of the caval vein. This route is mum essential medium (MEM) containing 0.85% agarose (Sigma Chemical, St Louis, MO, USA), 20 mm HEPES above the level of the clamping of the intrahepatic caval vein, which is just above the origin of the renal veins. In (pH 7.4), 12.3 mm MgCl 2 , 0.0025% l-glutamine, and 2% HS (heat-inactivated at 56°C for 30 min). In all experithe ILP experiments described here, the right suprarenal vein was neither clamped nor ligated.
ments, the plaque titer of CsCl-purified virus lots was well within 1 log of the OD titer (1 OD (260 nm) = 10
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In the present study we have demonstrated the feasibility of the ILP technique for the purpose of liverp.f.u. Small-scale production of adenovirus lots was perfordirected gene delivery with rAdV. We show that in vivo delivery of rAdV to the liver via ILP significantly reduces med as described. 23 Briefly, near confluent monolayers of 911 helper cells were infected with approximately 5 p.f.u. systemic leakage, and thus the unwanted exposure of non-target tissues to the rAdV. However, in the rat per cell. After 1 h at room temperature, the inoculum was replaced by fresh medium (DMEM/2% HS). After 48 h, model, systemic leakage could not be prevented completely. On the one hand, this is caused by the fact that in the nearly completely detached cells were harvested, and collected in 1 ml PBS/1% HS. Virus was isolated from small laboratory animals, ILP is a technically demanding surgical procedure. On the other hand, the leakage may the producer cells by three cycles of flash-freeze-thawing. The lysates were cleared by centrifugation at 800 g for be due to incomplete vascular isolation of the liver in the described ILP experiments. Currently, we are trying to 10 min. The crude virus supernatants were purified by double CsCl banding, dialysed, and stored at −80°C improve the ILP technique in an attempt to further reduce extrahepatic gene transfer. In addition, we anticiuntil further use. pate to evaluate the ILP procedure in a large animal model (pig, dog) to determine the extend of extrahepatic Animals Outbred male Wistar rats, weighing 200-250 g, were expression of the marker gene. We think that the isolated organ perfusion can be a useful procedure for the adminobtained from Harlan/CPB (Zeist, The Netherlands). Livers from adult Rhesus monkeys (Macaca mulatta), which istration of recombinant adenovirus vectors. However, considering the complexity of the procedure, the method had been killed to serve as kidney donors in other experiments, were obtained from the T.N.O. Institute for may be most useful for those gene therapy applications in which single adminstration of the virus is envisaged Applied Radiobiology and Immunology (Rijswijk, The Netherlands). Animals were kept at standard laboratory to suffice for a therapeutic effect, eg to transfer of suicide or cytokine genes for the treatment of cancer.
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conditions of alternating 12-h periods of light and darkness and a standard laboratory diet. All experiments were approved by the Animal Welfare Committee.
Materials and methods

Cells and cell culture
Surgical procedures Surgical procedures were performed under ether anesThe culture conditions for the 911 cells that were used for the production and titration of recombinant, E1-deleted, thesia in the rats, whereas ketamine chloride was used in the monkey experiments. For ex vivo perfusion rat experiadenovirus vectors have been described before. 23 For the in vitro and ex vivo perfusion experiments isolated hepaments, after a median laparotomy and the cannulation of the portal vein, the liver was removed and extracorportocytes were cultured in Williams E medium (Gibco Life Technologies, Grand Island, NY, USA) containing 10% ally perfused. Monkeys livers were perfused in situ with a Eurocollins solution via a cannula in the portal vein fetal calf serum and antibiotics and seeded into collagencoated dishes at a density of 5 × 10 6 cells/90 mm dish. which was inserted during the kidney donor procedure. Subsequently, the liver was removed and transported to The plates were maintained in a humidified incubator and kept constantly at 37°C. The medium was refreshed our laboratory. The left lateral liver lobe, weighing 40-60 g, was extracorporally separated from the rest of the liver every 24 h. Cell culture media, reagents, and sera were purchased from Gibco Laboratories (Grand Island, NY, and its portal vein(s) were cannulated for ex vivo perfusion as described below. The monkey liver is well USA). Culture plastics were purchased from Greiner (Nü rtingen, Germany).
suited for this purpose as the left lateral liver lobe is attached to the rest of the liver with only a vascular pedIn vivo gene delivery with adenovirus vectors For ex vivo perfusion the liver (lobes) of rat and monkey icle.
The surgical technique of isolated liver perfusion (ILP) origin were initially perfused with modified Berry buffers I (10 mm HEPES pH 7.4, 142 mm NaCl, 6.7 mm KCl, for has been previously described in detail. 25 After a median laparotomy, two limbs of inflow were established by 2 min) and II (100 mm HEPES pH 7.6, 57.6 mm NaCl, 6.7 mm KCl, 5.0 mm CaCl 2 , 20 mm d-glucose for 3 min, 26 and inserting cannulas into the pyloric branch of the portal vein and into the gastroduodenal branch of the common subsequently recirculated with 50 ml HEPES-buffered Hanks' solution (HH) solution for 15 min with 2 × 10 9 hepatic artery with their tips into the portal vein and the hepatic artery, respectively. The outflow cannula was p.f.u. Ad.RSV.␤-gal. During perfusion and recirculation performed at a flow rate of 50 ml/min, buffers were inserted into the caval vein under the liver. For a complete vascular isolation of the liver, all normal in-and gassed with a mixture of 95% air and 5% CO 2 and kept constantly at a temperature of 37°C and a pH of 7.4-7.6. outflow routes were clamped; the caval vein between liver and diaphragm and between the outflow cannula In addition, penicillin, streptomycin and fungizone were added to the buffers and HH. and the renal veins, the aorta proximal of the coeliac axis, the common hepatic artery and portal vein just proximal Two methods for ex vivo liver perfusion were employed to analyze the effect of chelating agents on the of the cannulas. A schematic representation of the ILP technique is shown in Figure 3 . For infusion into the porefficiency of gene transfer. Apart from the standard method, liver (lobes) were perfused with buffer I containtal vein (IPI), the pyloric branch of the portal vein was cannulated after a median laparotomy.
ing either 1 mm ethylene glycol tetra-acetate (EGTA) or 2 mm ethylene diamine tetra-acetate (EDTA; Sigma Chemical, St Louis, MO, USA) prior to the recirculation of the adenovirus vectors. In both methods, recirculation with adenovirus-containing buffer was followed by perfusion with fresh buffer II (without adenovirus) to wash out the non-bound virus. Subsequently, hepatocytes were isolated from the liver (lobes) and cultured in Williams E medium. After 48 h, the percentage of ␤-gal-positive cells was determined as described below. Isolation of rat and monkey hepatocytes was performed after the extra corporal perfusion of liver (lobes) and also to provide isolated liver cells for the in vitro experiments. For this purpose, we used modifications of the two-step collagenase perfusion technique of Seglen, 27 as described previously.
28,29 Digestion of rat livers was performed with collagenase type IV (Sigma Chemicals), whereas collagenase type B (Boehringer, Mannheim, Germany) was used to isolate hepatocytes from Rhesus monkey liver lobes. After removal of the liver capsule the softened liver was filtered through a 100-m nylon mesh, upon which the cells were washed twice in ice cold HH and once in ice cold Williams E medium supplemented with 10% fetal calf serum. Before culturing, the viability of the hepatocytes was determined by trypan blue exclusion. Hepatocyte preparations with Ͼ80% viability were seeded into collagen-coated dishes at a density of 5 × 10 6 cells per 90 mm dish. In the in vivo experiments (ILP and IPI), we used an adenovirus vector that carries a luciferase reporter gene (AdCMV-Luc). For ILP, the isolated liver circuit was, initially, perfused with 50 ml of Haemaccel to wash out the blood. Hereafter, the vascularly isolated liver was recirculated with 50 ml Haemaccel that contained 2 × 10 9 p.f.u. AdCMV-Luc. Following the recirculation of the vector-containing buffer, the liver was perfused with Haemaccel for another 10 min to wash out the non-bound virus. During perfusion and recirculation, which were performed at a flow rate of 20 ml per min in the portal Figure 3 Schematic representation of isolated liver perfusion. The surgical vein and 4.5 ml per min in the hepatic artery, the technique of isolated liver perfusion has previously been described in detail. 25 in 1 ml Haemaccel, in the cannulated portal vein, followed by the removal of the cannula and ligation of
